The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

This episode is sponsored by Endel, an app that creates personalized soundscapes to help you focus, relax and sleep. Could you enter a flow state with the people around you? Also, we've found a ...

Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight.

In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, ...

The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

GLP-1 medications significantly lower mortality rates in colon cancer patients. Research analyzed over 6,800 patients to establish drug effectiveness for survival. Higher survival rates observed with ...

(THE CONVERSATION) In the home, the lab and the factory, electric fields control technologies such as Kindle displays, medical diagnostic tests and devices that purify cancer drugs. In an electric ...

Cholesterol is a fat-like substance that moves through your blood. Your body actually needs some cholesterol because it helps build cells and make hormones. But if there’s too much cholesterol in your ...

Using human and mouse cells, as well as living lab mice, researchers found evidence that a common type of chemotherapy drug that blocks cancer cells from dividing, called taxanes, damages the brain's ...